After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
SOURCE Synthetic Biologics, Inc.
Shares of Synthetic Biologics are up 65% so far in 2015, due to high expectations for its 2016 gastrointestinal drugs.
Shares of Synthetic Biologics (SYN) are up 65% so far in 2015 due to high expectations for its gastrointestinal drugs.
Synthetic Biologics (SYN) shares are down after the company priced its secondary offering.
Stocks are in the red on Monday as markets prepare for next week's Federal Reserve meeting.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.